Back to News
Market Impact: 0.25

SMCI Quantitative Stock Analysis

SMCINDAQ
Company FundamentalsAnalyst InsightsTechnology & Innovation
SMCI Quantitative Stock Analysis

Validea's guru fundamental report indicates that Super Micro Computer Inc. (SMCI) receives a 59% rating based on their Warren Buffett-inspired "Patient Investor" model, which favors firms with predictable profitability, low debt, and reasonable valuations; while SMCI passes tests for earnings predictability, debt service, initial rate of return and expected return, it fails in return on equity, return on total capital, and free cash flow, suggesting mixed fundamentals despite overall positive attributes according to this specific guru strategy.

Analysis

Super Micro Computer Inc. (SMCI), a large-cap growth stock in the Computer Hardware sector, receives a 59% rating from Validea's Patient Investor model, which is based on Warren Buffett's strategy emphasizing predictable profitability, low debt, and reasonable valuations. This score, falling below the 80% threshold typically indicating 'some interest' by the model, reflects a mixed fundamental profile. SMCI successfully meets criteria for Earnings Predictability, Debt Service, Use of Retained Earnings, Initial Rate of Return, and Expected Return, suggesting elements of financial stability and potentially favorable valuation aspects. However, the company fails on critical metrics including Return on Equity, Return on Total Capital, and Free Cash Flow, highlighting potential weaknesses in its capital efficiency and ability to generate cash, despite the positive performance on other fundamental checks. The Share Repurchase criterion is assessed as Neutral, contributing to this nuanced evaluation rather than a clear endorsement by this specific investment strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.15

Ticker Sentiment

NDAQ0.00
SMCI-0.20

Key Decisions for Investors

  • Investors should interpret SMCI's 59% rating under the Validea Patient Investor model as an indication of mixed fundamental strength; while the company exhibits positive earnings predictability and debt management, significant concerns arise from its failure to meet standards for return on equity, return on total capital, and free cash flow.
  • Given that the 59% score is below the model's typical threshold for 'some interest', reliance on this specific Buffett-style strategy would necessitate a thorough investigation into the underlying causes of SMCI's suboptimal capital efficiency and cash generation metrics.
  • Consider that SMCI's profile presents a dichotomy between stable earnings/debt and weaker return/cash flow metrics, requiring careful evaluation of its suitability for a long-term, value-oriented portfolio, and potentially warranting cross-validation with other analytical frameworks before making investment decisions.